WRBC
VSEE

W.R. Berkley Corp’s VSee Health VSEE Stock Holding History

W.R. Berkley Corp’s Portfolio VSEE Stock Details VSEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-484,411
Closed -$4.91M – 355
2022
Q3 		$4.91M Buy
484,411
+57,700
+14% +$582K 0.24% 74
2022
Q2 		$4.28M Buy
426,711
+23,661
+6% +$237K 0.21% 88
2022
Q1 		$4.03M Buy
403,050
+268,050
+199% +$2.66M 0.21% 101
2021
Q4 		$1.33M Buy
+135,000
New +$1.33M 0.07% 303

Other funds holding VSEE

KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

W.R. Berkley Corp's VSEE Position: Q4 2022 in Review

W.R. Berkley Corp sold out of VSee Health (VSEE) in Q4 2022, closing a stake of 484,411 shares — an estimated $4.91M sold.

W.R. Berkley Corp first reported a position in VSEE in Q4 2021 and held it in 4 quarters. The position peaked at $4.91M in Q3 2022. 9 funds tracked by Wall St. Rank hold VSEE as of Q4 2022.

  • W.R. Berkley Corp reported no remaining VSee Health position as of Q4 2022 after selling out during the quarter.
  • W.R. Berkley Corp sold 484,411 VSee Health shares in Q4 2022, an estimated $4.91M.
  • W.R. Berkley Corp first reported a position in VSee Health in Q4 2021 and held it in 4 quarters.
  • W.R. Berkley Corp's VSee Health position peaked at $4.91M in Q3 2022.
  • 9 funds tracked by Wall St. Rank held VSee Health as of Q4 2022.

Based on W.R. Berkley Corp's 13F filing for Q4 2022, filed 14 Feb 2023.